NCT05911529Completed
Motivational Interviewing for Patients With Acute Psychosis
Source: ClinicalTrials.gov · Last updated 16 Jul 2024
Brief summary (registry, in English)
Psychotic disorders are associated with high levels of distress, limitations in quality of life, and a high risk of chronification for those affected. The treatment guidelines recommend combining the pharmacological treatment with psychotherapeutic methods, starting already in the acute phase. At the same time, there is little research evidence on which mechanisms of psychotherapy are most effective and best feasible for the acute setting. Therefore, the aim is to run a pilot study to test specific psychotherapeutic interventions for patients with psychosis on acute psychiatric wards. The method of "Motivational Interviewing" is a well-known and established interviewing technique, which originally comes from the treatment of addictive disorders. In this study, it is used to strengthen the therapeutic alliance between patient and practitioner already in the acute phase of the disease, to increase adherence, and thus to achieve the overall goal of better integrating patients with pronounced positive symptoms into treatment. This appears to be extremely important, as non-adherence represents one of the greatest risks for chronification of the disease. The intervention will subsequently be evaluated in comparison to "treatment as usual".
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 28 (actual)
- First submitted
- 2 May 2023
- Start date
- 15 Mar 2023
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Psychiatric University Hospital, Zurich
- Diseases
- Schizophrenia
- NCT number
- NCT05911529
What you commit to
- Study type: Interventional
- Participants enrolled: 28
- From 15 Mar 2023 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Drug or alcohol abuse during treatment
- Previous enrolment in the current study
- During study: Complete stop of taking antipsychotic medications
Other illness
- Organic schizophrenia-like disorder (ICD: F0.6)
Other
- Enrolment of the investigator, his/her family members, employees and other dependent persons
Who the study is looking for
- Informed consent as documented by signature
- Male and female patients from inpatient units of the Psychiatric University Hospital of Zurich
- ICD-10 diagnosis of psychosis (F2.x)
- Fluent in German and able to understand the instructions
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Psychiatric University Hospital Zurich Coordinator of this site? Confirm its status | Zurich | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.